Toward more selective therapies to block undesired immune responses
- 1 April 1989
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 35 (4), 1026-1033
- https://doi.org/10.1038/ki.1989.86
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The role of cachectin/TNF in endotoxic shock and cachexiaImmunology Today, 1988
- The regulation of intracellular signals during lymphocyte activationImmunology Today, 1988
- The two-chain structure of high-affinity IL-2 receptorsImmunology Today, 1987
- Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.The Journal of Experimental Medicine, 1987
- THE EFFECT OF ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY ON ALLOGRAFT REJECTIONTransplantation, 1985
- Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.The Journal of Experimental Medicine, 1985
- Characterization of a monoclonal rat anti-mouse interleukin 2 (IL-2) receptor antibody and its use in the biochemical characterization of the murine IL-2 receptorClinical Immunology and Immunopathology, 1985
- The early (18-hr) human mixed lymphocyte reaction: Identification and isolation of activated T-cell clonesCellular Immunology, 1985
- Neonatal Thymectomy Prevents Spontaneous Diabetes Mellitus in the BB/W RatScience, 1982
- Insulin-Dependent Diabetes Mellitus: The Initial LesionNew England Journal of Medicine, 1981